John Fraser receives funding from Health Research Council of New Zealand and the Wellcome Leap R3 Consortium for RNA. University of Auckland, Waipapa Taumata Rau provides funding as a member of The ...

An mRNA-based flu vaccine designed to offer long-lasting protection against a broad range of influenza viruses is now in a phase I clinical trial, the National Institutes of Health announced this week ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins. Two vaccine candidates using mRNA technology ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Dr. Bright is a virologist and a former head of the Biomedical Advanced Research and Development Authority. In early 2020, when the first genetic sequence of the new coronavirus was posted online, ...

mRNA vaccines were heralded as a medical marvel that saved lives during the Covid pandemic, but now the US is pulling back from researching them. US Health Secretary Robert F Kennedy Jr has cancelled ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...